The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a methanesulfonylalkylnitrile compound, or a pharmaceutically acceptable salt or solvate thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering a methanesulfonylalkylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
本发明涉及一种制药组合物,包括一种药用可接受载体和一种
甲烷磺酰基烷基
硝基化合物,或其药用可接受盐或溶剂。本发明还涉及一种治疗炎症、炎症相关疾病或疼痛的方法,通过向需要治疗的受体中给予
甲烷磺酰基烷基
硝基化合物或其药用可接受盐或溶剂。